Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Equity (2021 - 2025)

Journey Medical's Return on Equity history spans 5 years, with the latest figure at 0.4% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 55.0% year-over-year to 0.4%, compared with a TTM value of 0.4% through Dec 2025, up 55.0%, and an annual FY2025 reading of 0.44%, up 29.0% over the prior year.
  • Return on Equity for Q4 2025 was 0.4% at Journey Medical, down from 0.38% in the prior quarter.
  • The five-year high for Return on Equity was 3.16% in Q3 2021, with the low at 10.46% in Q2 2023.
  • Average Return on Equity over 5 years is 1.37%, with a median of 1.08% recorded in 2022.
  • Year-over-year, Return on Equity crashed -938bps in 2023 and then skyrocketed 1053bps in 2024.
  • Tracing DERM's Return on Equity over 5 years: stood at 2.9% in 2021, then surged by 53bps to 1.37% in 2022, then skyrocketed by 85bps to 0.2% in 2023, then plummeted by -362bps to 0.94% in 2024, then soared by 58bps to 0.4% in 2025.
  • Per Business Quant, the three most recent readings for DERM's Return on Equity are 0.4% (Q4 2025), 0.38% (Q3 2025), and 0.43% (Q2 2025).